{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:00:43Z","timestamp":1784779243117,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05380-z","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:20:38Z","timestamp":1777634438000},"page":"16557-16565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost effective industrial scale synthesis of bromo-benzo[b]azepinone: an intermediate for benazepril"],"prefix":"10.1007","volume":"399","author":[{"given":"Anjan Kumar","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya Bajpai","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Pendharkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"5380_CR1","unstructured":"APIFDF Analytics (2023) Benazepril analysis report. Available at: https:\/\/www.apifdf.com"},{"key":"5380_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2026.109308","author":"M Asad","year":"2026","unstructured":"Asad M, Usman M, Ashokan A, Kulkarni N (2026) Insilico engineering of transaminase variants for enhanced biocatalytic conversion of an ACE inhibitor precursor. J Mol Graph Model. https:\/\/doi.org\/10.1016\/j.jmgm.2026.109308","journal-title":"J Mol Graph Model"},{"issue":"1","key":"5380_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-025-10244-z","volume":"20","author":"AM Badawy","year":"2025","unstructured":"Badawy AM, Gad AM, Abdel-Maged AE, Michel HE, El-Naga RN, Azab SS (2025) Comparative study on the neuroprotective effects of perindopril and benazepril in experimentally-induced chronic mild stress in rats. J Neuroimmune Pharmacol 20(1):84","journal-title":"J Neuroimmune Pharmacol"},{"key":"5380_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.crgsc.2021.100229","volume":"5","author":"CH Benison","year":"2022","unstructured":"Benison CH, Payne PR (2022) Manufacturing mass intensity: 15 years of process mass intensity and development of the metric into plant cleaning and beyond. Curr Res Green Sustain Chem 5:100229","journal-title":"Curr Res Green Sustain Chem"},{"issue":"10","key":"5380_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jlcr.2580241005","volume":"24","author":"NK Chaudhuri","year":"1987","unstructured":"Chaudhuri NK, Patera R, Markus B, Sung M-S (1987) Synthesis of 14C-Labeled 3-([1-ethoxycarbonyl-3-phenyl-(1S)-propyl]amino)-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic Acid Hydrochloride ([14C]CGS 14824A). J Label Compd Radiopharm 24(10):1177\u20131184","journal-title":"J Label Compd Radiopharm"},{"key":"5380_CR6","unstructured":"ClinCalc DrugStats Database. (2022) Top 300 drugs of 2022. ClinCalc. Available at: https:\/\/clincalc.com\/DrugStats. Accessed 2024"},{"key":"5380_CR7","unstructured":"Dataintelo Market Research (2024) Global benazepril hydrochloride market report: industry trends, growth, and forecast to 2032. Dataintelo market research report. Available at: https:\/\/dataintelo.com\/report\/global-benazepril-hydrochloride-market"},{"key":"5380_CR8","unstructured":"DrugPatentWatch (2026) Benazepril sales data. Available at: https:\/\/www.drugpatentwatch.com\/subs\/drug-sales\/drugname\/BENAZEPRIL"},{"issue":"23","key":"5380_CR9","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1021\/jo00987a028","volume":"38","author":"PE Eaton","year":"1973","unstructured":"Eaton PE, Carlson GR, Lee JT (1973a) Phosphorus pentoxide-methanesulfonic acid. Convenient alternative to polyphosphoric acid. J Org Chem 38(23):4071\u20134407","journal-title":"J Org Chem"},{"issue":"23","key":"5380_CR10","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1021\/jo00987a028","volume":"38","author":"PE Eaton","year":"1973","unstructured":"Eaton PE, Carlson GR, Lee JT (1973b) Phosphorus pentoxide\u2013methanesulfonic acid: a convenient alternative to polyphosphoric acid. J Org Chem 38(23):4071\u20134073","journal-title":"J Org Chem"},{"issue":"17","key":"5380_CR11","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1016\/j.bmcl.2015.07.003","volume":"25","author":"C Fischer","year":"2015","unstructured":"Fischer C, Zultanski SL, Zhou H, Methot JL, Shah S, Hayashi I, Hughes BL, Moxham CM, Bays NW, Smotrov N, Hill AD, Pan B-S, Wu Z, Moy LY, Tanga F, Kenific C, Cruz JC, Walker D, Bouthillette M, Nikov GN, Shearman MS (2015) Discovery of novel triazolobenzazepinones as \u03b3-secretase modulators with central A\u03b242 lowering in rodents and rhesus monkeys. Bioorg Med Chem Lett 25(17):3488\u20133494","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"5380_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41256-023-00301-6","volume":"8","author":"MA Harrison","year":"2023","unstructured":"Harrison MA, Marfo AFA, Annan A, Ankrah DNA (2023) Access to cardiovascular medicines in low- and middle-income countries: a mini review. Glob Health Res Policy 8(1):17","journal-title":"Glob Health Res Policy"},{"issue":"5","key":"5380_CR13","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1021\/jo7024306","volume":"73","author":"Z-T Huang","year":"2008","unstructured":"Huang Z-T, Wang M-X (2008) A new strategy for the synthesis of 1,4-benzodiazepine derivatives based on the tandem N-alkylation\u2013ring opening\u2013cyclization reactions. J Org Chem 73(5):1979\u20131982","journal-title":"J Org Chem"},{"issue":"4","key":"5380_CR14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1021\/op200097d","volume":"15","author":"C Jimenez-Gonzalez","year":"2011","unstructured":"Jimenez-Gonzalez C, Ponder CS, Broxterman QB, Manley JB (2011) Using the right green yardstick: why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes. Org Process Res Dev 15(4):912\u2013917","journal-title":"Org Process Res Dev"},{"issue":"3","key":"5380_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000258","volume":"83","author":"JB King","year":"2026","unstructured":"King JB, An J, Bellows BK, Cohen JB, Commodore-Mensah Y, Ghazi L, Langford AT, Brook RD (2026) Single-pill combination therapy for the management of hypertension: a scientific statement from the American Heart Association. Hypertension 83(3):e00258","journal-title":"Hypertension"},{"issue":"10","key":"5380_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1161\/HYPERTENSIONAHA.125.25418","volume":"82","author":"CP McCarthy","year":"2025","unstructured":"McCarthy CP, McEvoy JW, Cluett JL (2025) Implementing the 2025 guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: leveraging evidence to push the boundaries of clinical care. Hypertension 82(10):1538\u20131540","journal-title":"Hypertension"},{"issue":"17","key":"5380_CR17","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1039\/D5OB00272A","volume":"23","author":"P Moghimi","year":"2025","unstructured":"Moghimi P, Sabet-Sarvestani H, Moghimi V, Norozi-Shad N, Szostak M (2025) Single-atom molecular editing: transformative advances in carbocyclic and heterocyclic frameworks. Org Biomol Chem 23(17):3982\u20134005","journal-title":"Org Biomol Chem"},{"issue":"18","key":"5380_CR18","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1039\/D5GC00958H","volume":"27","author":"M Nabi","year":"2025","unstructured":"Nabi M, Sharma K, Wandre RS, Gade AB (2025) One-pot oximation\u2013Beckmann rearrangement under mild, aqueous micellar conditions. Green Chem 27(18):5332\u20135339","journal-title":"Green Chem"},{"key":"5380_CR19","doi-asserted-by":"publisher","unstructured":"Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GFM (2024) Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.\u00a0Cochrane Database Syst Rev\u00a04(4):CD006257. https:\/\/doi.org\/10.1002\/14651858.CD006257.pub2","DOI":"10.1002\/14651858.CD006257.pub2"},{"issue":"28","key":"5380_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202502756","volume":"10","author":"S Rajendran","year":"2025","unstructured":"Rajendran S, Charbe NB, Amnerkar ND, Murugesan A, Khadse SC, Palakurthi SS, Chava SR, Prabha K, Acevedo R (2025) Comprehensive impact of Eaton\u2019s Reagent in organic synthesis: an overview. ChemistrySelect 10(28):e02756","journal-title":"ChemistrySelect"},{"key":"5380_CR21","unstructured":"Sonawane PP, Shinde A (2025) Formulation and evaluation of nanoparticulate drug delivery system of benazepril HCl. International Journal of Scientific Research and Technology 2(3)"},{"key":"5380_CR22","unstructured":"The Insight Partners (2026) Benazepril market dynamics, analysis, growth, trends and opportunities 2031. Report code: TIPRE00008642. Available at: https:\/\/www.theinsightpartners.com\/reports\/benazepril-market"},{"issue":"2","key":"5380_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/v15020508","volume":"15","author":"I Vosko","year":"2023","unstructured":"Vosko I, Zirlik A, Bugger H (2023) Impact of COVID-19 on cardiovascular disease. Viruses 15(2):508","journal-title":"Viruses"},{"key":"5380_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0959-6380(97)80010-4","volume":"9","author":"MA Walters","year":"1997","unstructured":"Walters MA, Vargas JR (1997) Five-membered ring systems: with more than one N atom. Prog Heterocyc Chem 9:148\u2013169","journal-title":"Prog Heterocyc Chem"},{"issue":"1","key":"5380_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08913-6","volume":"23","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wu S, Wang Z, Wang Y, Chen H, Wu C, Xiong L (2023) Long-term oral ACEI\/ARB therapy is associated with disease severity in elderly COVID-19 Omicron BA.2 patients with hypertension. BMC Infect Dis 23(1):882","journal-title":"BMC Infect Dis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05380-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:01:46Z","timestamp":1784775706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05380-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5380"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05380-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}